Analytical characterization of therapeutic peptides (GLP-1...)
Would you like to confirm the identity, purity, or integrity of a therapeutic peptide?
FILAB supports pharmaceutical and biotechnology companies in the analytical characterization of synthetic and therapeutic peptides, such as GLP-1 analogues, hormonal peptides, and other biomolecules of interest.
By combining liquid chromatography (HPLC/LC) and high-resolution mass spectrometry (HRMS/MS), our chemical engineers assess the main critical quality attributes (CQAs) of your peptides to secure their development, manufacturing, and quality control.
FILAB services for peptide characterization
FILAB provides comprehensive analytical characterization of therapeutic peptides, from quality control to impurity identification.
Determine peptide purity using HPLC-UV and LC-MS
Verify the peptide sequence using LC-HRMS/MS sequencing (peptide mapping)
Confirm molecular weight by LC-HRMS
Identify any impurities or structural modifications
Which peptides can be characterized?
GLP-1 analogues
KPV
DSIP
Pinealon
GHRP-6
Melanotan II
Oxytocin
Tirzepatide
synthetic peptides
HGH / Somatropin
innovative therapeutic peptides
hormonal peptides
Our analytical capabilities for peptide characterization
FAQ: Characterization of therapeutic peptides, including GLP-1
Therapeutic peptides are complex biomolecules whose structural properties directly influence their biological activity, stability, and safety of use. Their analytical characterization is an essential step in verifying compliance with regulatory requirements and ensuring the quality of manufactured batches.
Peptide analysis helps confirm their identity, assess their purity, detect any impurities or structural modifications, and verify sequence compliance for development, validation, or release phases.
Yes. Upon receipt of your request, a FILAB expert will discuss your project with you to understand its scope, the nature of your peptide and your objectives. This discussion helps define the most suitable analytical strategy, whether this involves identity confirmation, purity assessment, sequencing or impurity detection.
Yes. All relevant information can be found in this blog post: how to send your samples from France or abroad?
To prepare a suitable proposal, it is recommended that you specify the type of peptide being analyzed, its development stage, the analyses required and your objective (quality control, stability study, characterization, investigation, etc.). Our experts will then assist you in defining the most relevant analytical program.
To obtain a quote, you can contact our teams via our contact form, by telephone or by email.
Simply send us your requirements (type of material, requested analysis, applicable standard, urgency, quantity of samples, etc.). We will then send you a personalized technical and price proposal within 24–48 hours.
Turnaround times vary depending on the nature of the analysis and the complexity of the expert assessment project.
However, FILAB is committed to providing fast turnaround times tailored to your industrial constraints and urgent requirements.
FILAB characterizes various types of therapeutic peptides, including GLP-1 analogues, hormonal peptides, synthetic peptides and drug candidates developed in the pharmaceutical and biotechnology industries.
The combination of liquid chromatography and mass spectrometry makes it possible to confirm a peptide’s identity, measure its molecular mass, assess its purity and identify potential impurities or structural modifications with a high level of sensitivity.
